On August 2nd the Senate Appropriations Committee advanced the fiscal year (FY) 2025 Labor, HHS, Education, and Related Agencies Appropriations bill (Labor-HHS). The committee approved the spending bill with a bipartisan 25-3 vote.
When I was 20, I started having joint pain. Initially, I didn't even consider going to the doctor because I knew it would be dismissed, but after a few weeks the pain got so severe I had trouble doing the simplest everyday tasks.
Sharing her insights on autoimmune disease research and OADR's role in tackling them, Victoria Shanmugam, MBBS, MRCP, FACR, CCD, Director of the OADR, presented at the Society for Women's Health Research's (SWHR) March 2024 Policy Advisory Council meeting.
While it is unclear what makes someone more at risk for an autoimmune disease, constructs, such as race and ethnicity, and social determinants of health, including education level, income, and other socioeconomic measures, are known to have an impact on health outcomes.
SWHR attended MichBIO 2023 and gave the presentation “Addressing Disparities Through Patient, Provider, and Policymaker Collaborations: Women’s Health and Autoimmune Disease Case Study.”
To bring attention to these disparities and help support individuals impacted by lupus, SWHR added lupus to the Women’s Health Equity Initiative campaign this May, in recognition of Lupus Awareness Month.
This Lupus Awareness Month, SWHR is reflecting on the need for urgent action to close the gender, race, and ethnic disparities in lupus outcomes.
Recognizing the significant impact that diversity has on the nation's ability to improve autoimmune outcomes and advance health equity, SWHR developed the policy brief, “The Need for Diversity in Autoimmune Disease Research Trials.”
The SWHR policy brief, “Federal Agencies’ Work in Autoimmune Diseases and Conditions,” demonstrates how federal agencies are contributing to improved health and health care for women across the lifespan and why investments in these programs and initiatives should continue to be prioritized.